fluorodeoxyglucose f18 has been researched along with 6-deoxy-n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminoglucose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenter, C; Kosuge, H; McConnell, MV; Pratx, G; Xing, L; Zaman, RT | 1 |
| Chin, FT; Mahmoudi, M; McConnell, MV; Saito, T; Tuerkcan, S; Xing, L; Yang, PC; Zaman, RT | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and 6-deoxy-n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminoglucose
| Article | Year |
|---|---|
Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Carotid Artery Diseases; Diagnostic Imaging; Fiber Optic Technology; Fluorodeoxyglucose F18; Glucosamine; Male; Mice; Plaque, Atherosclerotic; Radionuclide Imaging; Radiopharmaceuticals | 2014 |
Imaging cellular pharmacokinetics of 18F-FDG and 6-NBDG uptake by inflammatory and stem cells.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Cell Line; Fluorodeoxyglucose F18; Glucosamine; Humans; Inflammation; Mice; Stem Cells | 2018 |